Target Complement system

Aus coViki
Wechseln zu: Navigation, Suche
  • GET ä. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 Extract
  • GET 2020. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience Extract
  • GET ä. Complement as a target in COVID-19? Extract
GET 2020. Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? Extract
  • GET 2020. Terminal complement inhibition dampens the inflammation during COVID-19. Extract
  • GET 2020. Complement activation in patients with COVID-19: A novel therapeutic target. Extract
  • GET 2020. Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Extract
  • GET 2020. Could severe COVID-19 be considered a complementopathy? Extract
Meine Werkzeuge